|
Synonyms: REGN-910 | REGN910 | SAR307746
Compound class:
Antibody
Comment: Nesvacumab is a fully human monoclonal antibody that targets angiopoietin-2 (ANGPT2, aka ANG2), being investigated as an antiangiogenic anti-tumour agent.
Peptide sequences for this antibody are available from its IMGT/mAb-DB record. |
Classification  |
|
| Compound class | Antibody |
| International Nonproprietary Names |
|
| INN number | INN |
| 9688 | nesvacumab |
| Synonyms |
| REGN-910 | REGN910 | SAR307746 |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 452 |
| Other databases | |
| GtoPdb PubChem SID | 252166667 |
| Search PubMed clinical trials | nesvacumab |
| Search PubMed titles | nesvacumab |
| Search PubMed titles/abstracts | nesvacumab |
| Wikipedia | Nesvacumab |
